Imaging for staging and response assessment in lymphoma Journal Article

Authors: Johnson, S. A.; Kumar, A.; Matasar, M. J.; Schöder, H.; Rademaker, J.
Article Title: Imaging for staging and response assessment in lymphoma
Abstract: Lymphoma comprises a heterogeneous group of diseases; remarkable advances have been made in diagnosis and treatment. Diagnostic imaging provides important information for staging and response assessment in patients with lymphoma. Over the years, staging systems have been refined, and dedicated criteria have been developed for evaluating response to therapy with both computed tomography (CT) and fluorine-18 fluorodeoxyglucose positron emission tomography (PET)/CT. The most recent system proposed for staging and response assessment, known as the Lugano classification, applies to both Hodgkin and non-Hodgkin lymphoma. The use of standardized criteria for staging and response assessment is important for making accurate treatment decisions and for determining the direction of further research. This review provides an overview of the updated CT and PET response criteria to familiarize the radiologist with the most important and clinically relevant aspects of lymphoma imaging. It also provides a short clinical update on lymphoma and the associated spectrum of imaging findings. © RSNA, 2015.
Keywords: cancer chemotherapy; treatment response; prednisone; clinical feature; review; doxorubicin; cancer radiotherapy; rituximab; cancer staging; nuclear magnetic resonance imaging; positron emission tomography; cancer diagnosis; sensitivity and specificity; carboplatin; dacarbazine; computer assisted tomography; multiple cycle treatment; etoposide; cyclophosphamide; vincristine; autologous stem cell transplantation; cancer therapy; ifosfamide; procarbazine; vinblastine; high risk patient; hodgkin disease; nonhodgkin lymphoma; drug uptake; contrast enhancement; echography; fluorodeoxyglucose f 18; computer assisted emission tomography; bleomycin; cancer classification; radiodiagnosis; cancer morphology; drug indication; cancer prognosis; human; priority journal; cancer treatment response assessment; disease assessment
Journal Title: Radiology
Volume: 276
Issue: 2
ISSN: 0033-8419
Publisher: Radiological Society of North America, Inc.  
Date Published: 2015-08-01
Start Page: 323
End Page: 338
Language: English
DOI: 10.1148/radiol.2015142088
PROVIDER: scopus
PUBMED: 26203705
Notes: Export Date: 2 September 2015 -- Source: Scopus
Altmetric Score
MSK Authors
  1. Heiko Schoder
    289 Schoder
  2. Matthew J Matasar
    122 Matasar
  3. Anita Kumar
    52 Kumar
Related MSK Work